biuro@scopefluidics.com +48 22 376 21 14
enpl
biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14

Category

Uncategorized
14
Apr

Scope Fluidics launches the BacterOMIC system prevalidation process

14.04.2020
Read More
18
May

Scope Fluidics has developed an ultra-fast PCR|ONE genetic test for coronavirus

18.05.2020
Read More
10
Jun

Scope Fluidics obtains patent protection for the PCR|ONE technology in China

10.06.2020
Read More
24
Jun

Subsidiary of Scope Fluidics receives a positive recommendation regarding ISO 13485:2016 compliance certification

24.06.2020
Read More
30
Jul

Scope Fluidics subsidiary obtains ISO 13485:2016 certification

30.07.2020
Read More
20
Aug

Scope Fluidics begins preparations for the accelerated registration procedure of the PCR|ONE SARS-CoV-2 panel in the USA

20.08.2020
Read More
07
Sep

EIB lends up to EUR 10 million to Scope Fluidics to develop diagnostics equipment for infectious diseases

07.09.2020
Read More
29
Sep

Scope Fluidics implements mass production of PCR|ONE system which detects bacterial and viral infections in 15 minutes

29.09.2020
Read More
30
Sep

Scope Fluidics intends to enter the Warsaw Stock Exchange regulated market in 2021

30.09.2020
Read More
04
Oct

Scope Fluidics launches a manufacturing line for the Bacteromic system

04.10.2020
Read More
1 … 7 8 9 10 11 … 14

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.

Recent Comments

    Tag Cloud

    home